Irinotecan
Top View
- How to Order Chemotherapy at Shands at the University of Florida - Inpatient
- Chemogenomic Screening Identifies the Hsp70 Co-Chaperone HDJ2 As
- HOPA News Volume 10, Issue 1
- And Irinotecan (FOLFIRI)
- Phase I Study of Irinotecan Combined with Mitomycin-C and 5
- Topoisomerase II Inhibitors Induce Cgas-STING Dependent Inflammation Resulting In
- CAPIRI (XELIRI Or Irinotecan & Capecitabine)
- (XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irino
- 5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers—Letter Osamu Maeda, Tomoya Shimokata, and Yuichi Ando
- GICIRB Protocol
- Capecitabine and Mitomycin C in Patients with Metastatic Colorectal Cancer Resistant to Fluorouracil and Irinotecan
- Capecitabine and Irinotecan As First- Line Chemotherapy for Patients with Metastatic Colorectal Cancer
- Irinotecan, Topotecan, Paclitaxel Or Docetaxel for Second-Line Treatment of Small Cell Lung Cancer
- Evaluation of Irinotecan in Combination with 5-Fluorouracil Or Etoposide in Xenograft Models of Colon Adenocarcinoma and Rhabdomyosarcoma
- The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: a Phase I Trial
- WHO Model List of Essential Medicines
- Dose Banding As an Alternative to Body Surface Area-Based Dosing of Chemotherapeutic Agents
- Chemogenomic Screening Identifies the Hsp70 Co-Chaperone DNAJA1